drugset / Trial / NCT06807762
Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare
NaSingle-groupOpen-labelTreatment
Summary
The goal of this Phase I clinical trial is to assess the pharmacokinetic availability and safety and tolerability profile of Extrato de Cannabis sativa GreenCare 79.14 mg/mL. The main question it aims to answer is: • Is the Extrato de Cannabis sativa GreenCare 79,14 mg/mL safe?
Timeline
- Start
- 2025-03-18
- Primary completion
- 2025-06
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabis oil | Unknown | 39.62 mg | — |
| Subject | Cannabis oil | Unknown | 791.4 mg | — |
Indications
No indication recorded.